Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Grin Therapeutics Inc.
Sponsor

Grin Therapeutics Inc.

United States 101 Main Street Suite 1210, 02142-1519, United States

About the sponsor

Grin Therapeutics Inc. focuses on clinical research in GRIN-related neurodevelopmental disorder, with attention to neurological and behavioral manifestations linked to altered NMDA receptor signaling.

  • GRIN-related neurodevelopmental disorder
  • Behavioral symptoms
  • Neurological function

The sponsor’s research activity in this area centers on pediatric and multisite evaluation of therapeutic effects relevant to cognition, behavior, and seizure-associated features.

About Specializations

Grin Therapeutics Inc. runs clinical trials in conditions such as Neurodevelopmental disorder, Tuberous sclerosis complex, Cortical dysplasia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Neurodevelopmental disorder

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Radiprodil
  • Sponsor:Grin Therapeutics Inc.

Tuberous sclerosis complex+1

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Radiprodil
  • Sponsor:Grin Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.